These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 33669532)
21. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M; Twisk FN; Ringel K Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503 [TBL] [Abstract][Full Text] [Related]
23. Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome. Maes M; Leunis JC Neuro Endocrinol Lett; 2014; 35(7):577-85. PubMed ID: 25617880 [TBL] [Abstract][Full Text] [Related]
25. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome. Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681 [TBL] [Abstract][Full Text] [Related]
26. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways. Morris G; Anderson G; Maes M Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535 [TBL] [Abstract][Full Text] [Related]
27. Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Castro-Marrero J; Cordero MD; Sáez-Francas N; Jimenez-Gutierrez C; Aguilar-Montilla FJ; Aliste L; Alegre-Martin J Antioxid Redox Signal; 2013 Nov; 19(15):1855-60. PubMed ID: 23600892 [TBL] [Abstract][Full Text] [Related]
28. Substrate utilisation of cultured skeletal muscle cells in patients with CFS. Tomas C; Elson JL; Newton JL; Walker M Sci Rep; 2020 Oct; 10(1):18232. PubMed ID: 33106563 [TBL] [Abstract][Full Text] [Related]
29. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818 [TBL] [Abstract][Full Text] [Related]
30. Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Schreiner P; Harrer T; Scheibenbogen C; Lamer S; Schlosser A; Naviaux RK; Prusty BK Immunohorizons; 2020 Apr; 4(4):201-215. PubMed ID: 32327453 [TBL] [Abstract][Full Text] [Related]
31. Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Booth NE; Myhill S; McLaren-Howard J Int J Clin Exp Med; 2012; 5(3):208-20. PubMed ID: 22837795 [TBL] [Abstract][Full Text] [Related]
32. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546 [TBL] [Abstract][Full Text] [Related]
33. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus? Hatziagelaki E; Adamaki M; Tsilioni I; Dimitriadis G; Theoharides TC J Pharmacol Exp Ther; 2018 Oct; 367(1):155-167. PubMed ID: 30076265 [TBL] [Abstract][Full Text] [Related]
34. Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patients. Marshall-Gradisnik S; Johnston S; Chacko A; Nguyen T; Smith P; Staines D J Int Med Res; 2016 Dec; 44(6):1381-1394. PubMed ID: 27834303 [TBL] [Abstract][Full Text] [Related]
35. Pre-illness data reveals differences in multiple metabolites and metabolic pathways in those who do and do not recover from infectious mononucleosis. Jason LA; Conroy KE; Furst J; Vasan K; Katz BZ Mol Omics; 2022 Aug; 18(7):662-665. PubMed ID: 35640165 [TBL] [Abstract][Full Text] [Related]